Author name: kcahill@epl-inc.com

Reading Time: 2 minutesSince 1971, EPL has developed and refined methods to provide high quality and efficient histopathology services. The following information details some of the steps taken during histology processing and preparation at EPL, to ensure tissue accountability and define routine tissue recut procedures. Tissue Accountability on All Studies: Each study received at EPL will be assigned […]

Reading Time: 2 minutesIn 2017, EPL has conducted 189 pathology peer reviews, including 28 peer reviews on 2-year carcinogenicity studies and transgenic rasH2 mouse 26-week carcinogenicity projects.  Each project requires set up of our unique peer review system ahead of the actual peer review conduct. Our PQA software program is a computerized pathology peer review procedure developed at

Reading Time: 2 minutesWith the processing of up to 50,000 tissues per month, and projects regularly flowing in and out of our labs, histology scheduling at EPL is a continual process. Recognizing that the project timeline, in addition to quality and expertise, is one of the most important factors to our clients, we’re providing the following tips on

Reading Time: 2 minutesWhen selecting a Pathology Peer Review provider, experience is an important factor to consider in order to ensure high quality pathology data.  Over the last two years alone, EPL has conducted more than 250 pathology peer reviews.  These pathology peer reviews have been conducted internationally, with reviews being performed across North America, Asia, and Europe. 

Reading Time: 5 minutesAclairo® Pharmaceutical Development Group, Inc. is committed to delivering independent and objective nonclinical and regulatory advice to the pharmaceutical industry. Every member of Aclairo’s staff strives to provide our clients with superior advice, analysis, work product and program assistance. Aclairo’s unique experience and capabilities help our clients’ development programs succeed. Our senior consultants are experienced ex-FDA

Reading Time: < 1 minuteThe Standard for Exchange of Nonclinical Data (SEND) provides preclinical study data standards that will allow for a more consistent and streamlined review process by the US FDA.  In general, SEND formats apply to studies started after Dec. 17, 2016 for NDAs, BLAs, and ANDAs, and studies that start after Dec. 17, 2017 for INDs.

Reading Time: 2 minutesEPL is pleased to announce that our veterinary pathology staff will once again be associated with multiple presentations and scientific posters at The 36th Society of Toxicologic Pathology (STP) Annual Symposium to be held in Montreal, Quebec from June 24-29, 2017.  The focus of this year’s symposium is the musculoskeletal system. EPL will have three pathologists

Reading Time: < 1 minuteDr. Tom Steinbach from EPL will be the featured speaker for the Webinar titled, “Using Electron Microscopy in Nonclinical Studies,” which is jointly sponsored by the Society of Toxicologic Pathology-India (STP-I), International Federation of Societies of Toxicologic Pathologists (IFSTP), and International Academy of Toxicologic Pathology (IATP). This webinar will be held on Thursday, May 25,

Reading Time: < 1 minuteDr. Jeff Wolf from EPL will be participating as a chair and speaker at the 2017 STP Regional Meeting focusing on Environmental Toxicologic Pathology.  The event is organized by the Society of Toxicologic Pathology’s Environmental Toxicologic Pathology Special Interest Group (ETP–SIG) and will be held at the National Toxicology Program/NIEHS Headquarters in Research Triangle Park,

Reading Time: 2 minutesExperimental Pathology Laboratories, Inc. (EPL), and West China-Frontier PharmaTech Co., Ltd. (WCFP) announce a Strategic Alliance to enhance Preclinical Services. This alliance is targeted to bolster the rapid growth of WCFP by specifically providing EPL’s Pathology Peer Review Services for WCFP projects that are being submitted to international regulatory agencies. WCFP is experiencing rapid growth